FDA inspection of Ranbaxy closes New Jersey facility

FDA inspection of Ranbaxy closes New Jersey plant She said the permit should ohm set up to treat more valuable first-to-file products as a generic o...


FDA inspection of Ranbaxy closes New Jersey plant
She said the permit should ohm set up to treat more valuable first-to-file products as a generic of Novartis’ ($ NVS) Diovan blood pressure med, which went off patent over a year ago. Ranbaxy was expected to bring his exclusive generic …
Read more at

Leave a Reply